Publication | Open Access

Cetuximab, docetaxel, and cisplatin as first-line treatment in patients with recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, phase II GORTEC study

Neoadjuvant TherapyMedicinePathologyFirst-line TreatmentHead And Neck CancerCancer TreatmentNeck OncologyOncologyRadiation OncologyMetastatic Head